Department of Pharmacology, EMAN Testing and Research Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang, Malaysia.
Department of Pharmaceutical Engineering, Faculty of Engineering Technology, University Malaysia Pahang, Gambang, Malaysia.
Indian J Pharmacol. 2019 Jan-Feb;51(1):45-54. doi: 10.4103/ijp.IJP_312_18.
Sophorolipids (SLs) are a group of surface-active glycolipids produced by a type of nonpathogenic yeast in the presence of vegetable oil through fermentation technology. SLs have shown antitumor activity; however, the mechanism of action underlying the anticancer activity of SLs is poorly understood. This work evaluated the anticancer activity of SLs fermented from palm oil by exploring its antiangiogenic activity.
The SLs that were fermented and further characterized for their biochemical activities. Cytotoxicity study was performed to assess cytostatic properties. A series of and angiogenesis assay was also carried out. The relative fold change in the expression of p53 mRNA by SLs was also studied.
Altogether, the data show that SLs derived from palm oil fermentation process inhibited neovascularization in the tissue segments and also the endothelial cell proliferation between 50% and 65% inhibition as a whole. The palm oil derived SLs also caused downregulation of the suppression level of vascular endothelial growth factor and also upregulate the p53 mRNA level. The analytical studies revealed the presence of high amount of phenolic compounds but with relatively weak antioxidant activity. The gas chromatography-mass spectrometry studies revealed abundant amount of palmitic and oleic acid, the latter an established antiangiogenic agent, and the former being proangiogenic.
Therefore, it can be concluded from this study that SLs derived from fermented palm oil have potent antiangiogenic activity which may be attributed by its oleic acid component.
槐糖脂(SLs)是一组由非致病性酵母在植物油存在下通过发酵技术产生的具有表面活性的糖脂。SLs 具有抗肿瘤活性;然而,其抗癌活性的作用机制尚不清楚。本工作通过探索其抗血管生成活性来评估由棕榈油发酵而来的 SLs 的抗癌活性。
对发酵得到的 SLs 进行了进一步的生化特性表征。进行了细胞毒性研究以评估其细胞抑制特性。还进行了一系列的 和 血管生成测定。还研究了 SLs 对 p53 mRNA 表达的相对变化倍数。
总的来说,数据表明棕榈油发酵过程衍生的 SLs 抑制了 组织段中的新生血管形成,并且还抑制了内皮细胞增殖,总体抑制率为 50%至 65%。棕榈油衍生的 SLs 还导致血管内皮生长因子的抑制水平下调,并上调 p53 mRNA 水平。分析研究表明存在大量酚类化合物,但抗氧化活性相对较弱。气相色谱-质谱研究表明存在大量的棕榈酸和油酸,后者是一种已建立的抗血管生成剂,而前者是促血管生成的。
因此,从这项研究可以得出结论,由发酵棕榈油衍生的 SLs 具有潜在的抗血管生成活性,这可能归因于其油酸成分。